John Bernard Payne is President and CEO of Zivo Bioscience, Inc.. Currently has a direct ownership of 7,909 shares of ZIVO, which is worth approximately $165,219. The most recent transaction as insider was on Oct 16, 2024, when has been sold 6,343 shares (Common Stock) at a price of $15.76 per share, resulting in proceeds of $99,965. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.91K
15.87% 3M change
15.87% 12M change
Total Value Held $165,219

JOHN BERNARD PAYNE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 16 2024
BUY
Open market or private purchase
$99,965 $15.76 p/Share
6,343 Added 44.51%
7,909 Common Stock
Dec 19 2022
BUY
Open market or private purchase
$142 $2.5 p/Share
57 Added 0.6%
9,401 Common Stock
Jan 27 2022
BUY
Open market or private purchase
$115 $2.5 p/Share
46 Added 0.49%
9,344 Common Stock
Jan 25 2022
BUY
Open market or private purchase
$22,805 $2.5 p/Share
9,122 Added 49.52%
9,298 Common Stock
Sep 09 2020
SELL
Payment of exercise price or tax liability
$25,943 $0.11 p/Share
235,849 Reduced 94.34%
14,151 Common Stock
Sep 09 2020
BUY
Exercise of conversion of derivative security
$25,000 $0.1 p/Share
250,000 Added 50.0%
250,000 Common Stock
JBP

John Bernard Payne

President and CEO
Vancouver, WA

Track Institutional and Insider Activities on ZIVO

Follow Zivo Bioscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZIVO shares.

Notify only if

Insider Trading

Get notified when an Zivo Bioscience, Inc. insider buys or sells ZIVO shares.

Notify only if

News

Receive news related to Zivo Bioscience, Inc.

Track Activities on ZIVO